Speeding innovation for industry
CES 2019 : CEA Tech to exhibit at CES Las Vegas on January 8–11
DIABELOOP: Artificial pancreas for type-1 diabetics.
Diabeloop is a French independent company developing disruptive
technological innovations to automate the treatment of Type one
Its first product, the DBLG1 System, is an integrated
system that allows glycemic control in an automatic and highly efficient
way. The core of this innovation is an Artificial Intelligence hosted
on a terminal that connects via bluetooth with a continuous glucose
meter (CGM) and an insulin pump.
The algorithm makes and executes
the many therapeutic decisions that the patients currently have to
handle by themselves. Patients are only expected to log meals and
• E-healthcare• Medical devices• Therapeutic innovation• Artificial intelligence
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.